Monoclonal antibody therapy is a type of cancer treatment that uses antibodies to target and destroy cancer cells. Antibodies are proteins that are produced by the body’s immune system to target and destroy foreign substances, such as viruses and bacteria. Monoclonal antibodies are man-made versions of these natural antibodies.
Monoclonal antibody therapy can be used to treat a number of different types of cancer, including breast cancer, colorectal cancer, non-Hodgkin’s lymphoma, and ovarian cancer. Monoclonal antibody therapy can be used alone or in combination with other cancer treatments, such as chemotherapy and radiation therapy.
There are a number of different monoclonal antibodies that are approved by the US Food and Drug Administration (FDA) for the treatment of cancer, including trastuzumab (Herceptin), rituximab (Rituxan), and bevacizumab (Avastin).
Monoclonal antibody therapy is generally well-tolerated, with the most common side effects being fatigue, fever, and chills. More serious side effects can occur, but are rare.
Monoclonal antibody therapy is a promising cancer treatment that is continually being studied in clinical trials for the treatment of a variety of different types of cancer.
Monoclonal antibody therapy is a type of cancer treatment that uses antibodies to target and destroy cancer cells. Antibodies are proteins that are produced by the body’s immune system to identify and neutralize foreign substances, such as bacteria and viruses. Monoclonal antibodies are man-made versions of these natural proteins.
Monoclonal antibody therapy can be used to treat a variety of cancers, including leukemia, lymphoma, and breast, lung, and colon cancer. It can also be used to treat certain autoimmune diseases, such as rheumatoid arthritis and Crohn’s disease.
Monoclonal antibody therapy is generally considered to be safe and well-tolerated. The most common side effects are mild and include fatigue, nausea, and diarrhea.
Monoclonal antibody therapy is a promising new cancer treatment that is still being studied. It offers the potential to specifically target and destroy cancer cells with minimal side effects.
